of serotonin (5-HT) on plasma glucose and serum insulin levels were studied in mice. In normal mice, 5-HT induced a dose-dependent hypo glycemia and an increase in serum insulin levels. 5-HT significantly inhibited glucose-induced hyperglycemia and increased glucose-stimulated insulin release. However, in streptozotocin-induced diabetic mice, 5-HT changed neitheir the glucose nor insulin levels. These results strongly suggest that 5-HT-induced hypoglycemia is brought on by increasing serum insulin levels.
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in the liver may also contribute to the hypoglycemic effects of 5-HT. In this paper, therefore, to clarify the involvement of insulin in hypoglycemia induced by 5-HT, we investigated the effects of 5-HT on blood glucose and insulin levels using glucose and streptozotocin-treated mice.
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Male ddY mice weighing 25-30 g were purchased from SLC Japan, Inc. (Shizuoka, Japan). Mice were housed in a room with a controlled 12 hr/12 hr light/dark cycle, with lights on between 7:00 a.m. and 7:00 p.m., a temperature of 24±1 °C and at a humidity of 55 + 5%. Experiments were performed between 1:00 and 5:00 p.m. Mice were starved for [18] [19] [20] hr before the injection of 5-HT. Serotonin creatinine sulfate monohydrate (5 HT) and glucose were purchased from Merck (Darmstadt, West Germany) and Wako Pure Chemical Industries (Osaka, Japan), respec tively. 5-HT and glucose were dissolved in saline and given i.p. simultaneously. Strep tozotocin was obtained from Sigma Chemical Co. (St. Louis, U.S.A.). Streptozotocin was freshly dissolved in ice-cold citrate buffer (pH 4.5) and administered i.v. from the tail vein. Streptozotocin at 250 mg/kg was injected 7 days before the injection of 5-HT. Drugs were given at a volume of 0.1 ml/10 g body weight. Blood samples were taken from the caudal vena cava under light ether anesthesia 30 min after the injection of 5-HT. Only one sample was removed from each mouse. Plasma glucose was determined with glucose oxidase and peroxidase using a Wako Glucose C-test kit from Wako Pure Chemical Industries (Osaka, Japan). Serum insulin levels were determined as immunoreactive insulin (IRI) using a double-antibody radio immunoassay kit (Insulin RIA Beads, Dinabot RI Institute, Tokyo, Japan). Statistical sig nificance was evaluated by Student's t-test between two groups. For three or more groups, analysis of variance was performed followed by Duncan's multiple range test or Dunnet's test when appropriate. Figure 1 shows the effects of 5-HT on the plasma glucose and serum insulin levels of normal mice. 5-HT produced a significant hypoglycemia and increase in serum insulin levels. Both effects were elicited above the dosage of 20 mg/kg. The administration of 5-HT at 120 mg/kg induced about a 49% decrease in plasma glucose and about a 184% increase in serum insulin levels com pared to the control group. Figure 2 demonstrates the effects of 5-HT on plasma glucose and serum insulin levels in glucose and streptozotocin-treated mice. Glucose at 1 g/kg induced significant in creases in glucose and insulin levels. 5-HT significantly reduced glucose-induced hyper glycemia and enhanced insulin release stimulated by glucose. Streptozotocin at 250 mg/kg induced a remarkable hyper glycemia and a significant decrease in insulin levels. However, 5-HT affected neither the plasma glucose nor the serum insulin levels of streptozotocin-induced diabetic mice. We previously reported that 5-HT induces dose-dependent hypoglycemia in fasted mice (7). As shown in Fig. 1A , we confirmed the effects of 5-HT on plasma glucose. In this study, we found that the hyperinsulinemic effects of 5-HT are also dose-dependent (Fig.  1 B) . It has been reported that 5-HTP, the precursor of 5-HT, causes hypoglycemia and hyperinsulinemia in mice, and its effects are due to the formation of 5-HT (5, 6). The effects of 5-HT in our present results support these previous findings. As shown in Fig. 1 , it seems that hyperinsulinemia is concomitant with hypoglycemia.
This idicates that hypo glycemia elicited by 5-HT may be brought on by increasing insulin release. To elucidate the involvement of insulin in 5-HT-induced hypoglycemia, we examined the effects of 5-HT in glucose and strep tozotocin-treated mice. Previous studies indicated that 5-HT enhances or decreases glucose-induced insulin release among dif ferent species or experimental conditions (3, 10, 11 ), although the reason for these discrepancies remains unclear. As shown in our results, 5-HT inhibited glucose-induced hyperglycemia and enhanced the increase in serum insulin levels elicited by glucose. It indicates the involvement of insulin in the hypoglycemic effects of 5-HT in mice. Streptozotocin is recognized to induce diabetes in experimental animals characterized by hyperglycemia and hypoinsulinemia, since it destroys pancreatic B cells and decreases the stores of insulin (12). As shown in Fig. 2 , streptozotocin induced remarkable hyper glycemia and significant decreases in serum insulin levels. However, 5-HT did not induce hypoglycemia nor hyperinsulinemia in strep tozotocin-treated diabetic mice. It strongly suggests that the effects of 5-HT are de pendent on insulin release. Taken together, it leads to the conclusion that hypoglycemia induced by 5-HT is elicited by increasing insulin release. Glucose at 1 g/kg was given i.p. Glucose and 5-HT were injected simultaneously.
Streptozotocin at 250 mg/kg was given i.v. at 7 days before the injection of 5-HT. Blood samples were taken 30 min after the injection of 5-HT. **P--0.01, ***P<0.001, significant difference from the saline administered mice of the respective group. -,~TP <0.05, **P<0.0 i, significant difference from the saline administered normal mice.
5-HT is known to be abundantly present in the pancreatic islets of several species including mice, rats or rabbits (13). In ad dition, it has been demonstrated that pancre atic islets have mechanisms for the uptake of 5-HT and form 5-HT from the precursor 5 HTP (14, 15). These evidence together with our present results suggest that 5-HT may control the blood glucose levels by affecting the mechanisms for insulin release in pancre atic B cells. It is probably mediated by 5-HT receptors, since we have demonstrated in our previous study (7) 
